Skip to main navigation Skip to search Skip to main content

Low Dose Abdonminal Radiotherapy as a Taxotere Chemosensitizer for Recurrent/Persistent or Advanced Ovarian Carcinoma

Grants and Contracts Details

StatusFinished
Effective start/end date3/1/02 → 4/30/04

Funding

  • Aventis Pharmaceuticals Products Inc: $7,538.00